{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:43:31Z","timestamp":1784346211017,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.bcmd.2014.07.018","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T13:58:46Z","timestamp":1412690326000},"page":"65-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Cystatin C: A useful marker of glomerulopathy in sickle cell disease?"],"prefix":"10.1016","volume":"54","author":[{"given":"Monika","family":"Asnani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2014.07.018_bb0005","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1056\/NEJMc066547","article-title":"Elderly survivors with homozygous sickle cell disease","volume":"356","author":"Serjeant","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0010","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7326\/0003-4819-115-8-614","article-title":"Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality","volume":"115","author":"Powars","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5414\/CNP58009","article-title":"Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival","volume":"58","author":"Abbott","year":"2002","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0020","first-page":"81","article-title":"A survey of chronic renal failure in Jamaica","volume":"53","author":"Barton","year":"2004","journal-title":"West Indian Med. J."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.6002\/ect.2011.0098","article-title":"Sickle cell and renal transplant: a national survey and literature review","volume":"10","author":"Nath","year":"2012","journal-title":"Exp. Clin. Transplant."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0030","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1136\/bmj.311.7020.1600","article-title":"Improved survival in homozygous sickle cell disease: lessons from a cohort study","volume":"311","author":"Lee","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.bcmd.2014.07.018_bb0035","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ajh.21676","article-title":"Sickle cell disease in the United States: looking back and forward at 100years of progress in management and survival","volume":"85","author":"Prabhakar","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0040","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1182\/blood-2003-11-3758","article-title":"Survival of children with sickle cell disease","volume":"103","author":"Quinn","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2014.07.018_bb0045","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0050","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.285.6342.633","article-title":"Causes of death in sickle-cell disease in Jamaica","volume":"285","author":"Thomas","year":"1982","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.bcmd.2014.07.018_bb0055","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"Kidney Foundation","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0060","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2141.2011.08853.x","article-title":"Sickle cell nephropathy\u2014a practical approach","volume":"155","author":"Sharpe","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0065","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.mcna.2004.11.009","article-title":"Measurement of kidney function","volume":"89","author":"Stevens","year":"2005","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0070","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0075","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0080","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0085","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function\u2014measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-13-83","article-title":"Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: a prospective observational cohort study","volume":"13","author":"Arlet","year":"2012","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0095","doi-asserted-by":"crossref","first-page":"e69922","DOI":"10.1371\/journal.pone.0069922","article-title":"Determining glomerular filtration rate in homozygous sickle cell disease: utility of serum creatinine based estimating equations","volume":"8","author":"Asnani","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcmd.2014.07.018_bb0100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/clinchem\/48.5.699","article-title":"Cystatin C: an improved estimator of glomerular filtration rate?","volume":"48","author":"Laterza","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1515\/CCLM.1999.064","article-title":"Serum cystatin C as an endogenous marker of the renal function\u2014a review","volume":"37","author":"Randers","year":"1999","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2004.09.025","article-title":"Cystatin C as a marker of GFR\u2014history, indications, and future research","volume":"38","author":"Filler","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0115","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1515\/CCLM.2008.336","article-title":"Cystatin C: current position and future prospects","volume":"46","author":"Seronie-Vivien","year":"2008","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","article-title":"Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis","volume":"40","author":"Dharnidharka","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0125","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2011.468","article-title":"Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality","volume":"305","author":"Peralta","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bcmd.2014.07.018_bb0130","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0135","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.mnh.0000222694.07336.92","article-title":"Update on cystatin C: new insights into the importance of mild kidney dysfunction","volume":"15","author":"Shlipak","year":"2006","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0140","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/pbc.21520","article-title":"Short-term follow-up of patients with sickle cell disease and albuminuria","volume":"50","author":"Alvarez","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bcmd.2014.07.018_bb0145","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00467-006-0033-6","article-title":"Serum cystatin C levels in children with sickle cell disease","volume":"21","author":"Alvarez","year":"2006","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0150","doi-asserted-by":"crossref","DOI":"10.1007\/s00467-011-1857-2","article-title":"Glomerular hyperfiltration and albuminuria in children with sickle cell anemia","author":"Aygun","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0155","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/jcp.2005.026799","article-title":"Comparison of renal function markers in Kuwaiti patients with sickle cell disease","volume":"59","author":"Marouf","year":"2006","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0160","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/sj.ki.5000248","article-title":"Early markers of renal dysfunction in patients with sickle cell\/beta-thalassemia","volume":"69","author":"Voskaridou","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0165","first-page":"137","article-title":"Determination of creatinine in human serum by isotope dilution-mass spectrometry. Definitive methods in clinical chemistry, IV","volume":"23","author":"Siekmann","year":"1985","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and Cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0175","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/ndt\/gfg349","article-title":"A comparison between Cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate","volume":"18","author":"Hoek","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00365510410003723","article-title":"Calculation of glomerular filtration rate expressed in mL\/min from plasma cystatin C values in mg\/L","volume":"64","author":"Larsson","year":"2004","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.24100","article-title":"Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled baby hug clinical trial for infants with sickle cell anemia","author":"Alvarez","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bcmd.2014.07.018_bb0190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpeds.2009.06.060","article-title":"Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial","volume":"156","author":"Ware","year":"2010","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0195","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00467-011-1857-2","article-title":"Glomerular hyperfiltration and albuminuria in children with sickle cell anemia","volume":"26","author":"Aygun","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0200","article-title":"Cystatin C, Beta2 microglobulin, N-acetyl-beta-D-glucosaminidase, retinol-binding protein, and endothelin 1 levels in the evaluation of sickle cell disease nephropathy","author":"Unal","year":"2013","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0205","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jcp.43.5.370","article-title":"Measurement of glomerular filtration rate in homozygous sickle cell disease: a comparison of 51Cr-EDTA clearance, creatinine clearance, serum creatinine and beta 2 microglobulin","volume":"43","author":"Aparicio","year":"1990","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0210","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archinte.167.7.701","article-title":"Albuminuria and renal function in homozygous sickle cell disease: observations from a cohort study","volume":"167","author":"Thompson","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0215","doi-asserted-by":"crossref","first-page":"e18863","DOI":"10.1371\/journal.pone.0018863","article-title":"Higher rates of hemolysis are not associated with albuminuria in Jamaicans with sickle cell disease","volume":"6","author":"Asnani","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcmd.2014.07.018_bb0220","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/archdischild-2011-300628","article-title":"Prevalence and predictors of microalbuminuria in Jamaican children with sickle cell disease","volume":"96","author":"King","year":"2011","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0225","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s00467-010-1560-8","article-title":"Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia","volume":"25","author":"Gurkan","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0230","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bcmd.2010.08.001","article-title":"Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia","volume":"45","author":"Maier-Redelsperger","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0235","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1681\/ASN.2002010084","article-title":"Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure","volume":"17","author":"Guasch","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0240","doi-asserted-by":"crossref","first-page":"e2095","DOI":"10.1371\/journal.pone.0002095","article-title":"Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain","volume":"3","author":"JGt","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcmd.2014.07.018_bb0245","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/j.ajkd.2012.03.011","article-title":"Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"60","author":"Waheed","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0250","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2011.10.900","article-title":"Cardiovascular abnormalities in sickle cell disease","volume":"59","author":"Gladwin","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0255","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0260","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1523-1755.2004.00517.x","article-title":"Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement","volume":"65","author":"Knight","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0265","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0272-6386(12)81022-5","article-title":"Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study","volume":"16","author":"Perrone","year":"1990","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0270","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/ndt\/14.7.1673","article-title":"Glomerular filtration rate estimated from the uptake phase of 99mTc-DTPA renography in chronic renal failure","volume":"14","author":"Petersen","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bcmd.2014.07.018_bb0275","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1042\/cs0660613","article-title":"Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man","volume":"66","author":"Rehling","year":"1984","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bcmd.2014.07.018_bb0280","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1681\/ASN.2009020171","article-title":"Measured GFR as a confirmatory test for estimated GFR","volume":"20","author":"Stevens","year":"2009","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614000977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979614000977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:31:21Z","timestamp":1761049881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979614000977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1079979614000977"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.07.018","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystatin C: A useful marker of glomerulopathy in sickle cell disease?","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2014.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}